
TRIDERM LENIL PALPEBRAL eyelid cream minitube, 15 ml
Original title: TRIDERM LENIL PALPEBRAL CREAM MINITUBE 15ML
- Tirana 0–1 daysFree
- Other cities 1–2 daysshop's ratefree from 3 000 ALL
- Price updated Oct 20, 2026, 6:12 PM
TRIDERM LENIL PALPEBRAL CREAM MINITUBE 15ML - Soothing Relief for Eyelid Irritation
Experience immediate relief from redness, dryness, and itching on your eyelids with TRIDERM LENIL PALPEBRAL CREAM. This gentle, ophthalmologist-tested cream is designed for both children and adults, offering soothing and softening properties to combat eyelid irritation and prevent further dryness and discomfort.
Formulated with powerful ingredients like AD RESYL® and CERAMIDE NG, this cream works to restore the skin's natural barrier function, enhance hydration, rebalance the skin's microbiome, and reduce reactivity. AD RESYL® provides multi-functional care, promoting healing and improving skin's overall health, while CERAMIDE NG strengthens the skin barrier and supports repair processes.
Key Ingredients:
- AD RESYL®: Restores barrier function, boosts hydration, rebalances microbiome, reduces skin reactivity.
- CERAMIDE NG: Strengthens the skin barrier, supports skin repair.
- Panthenol: Soothes and hydrates.
- Shea Butter: Provides moisturizing and emollient properties.
- Sodium Hyaluronate: Hydrates and plumps the skin.
Full Ingredient List: aqua (water), isononyl isononanoate, pentylene glycol, cetearyl alcohol, tapioca starch, C10- 18 triglycerides, arachidyl alcohol, butyrospermum parkii butter (butyrospermum parkii (shea) butter), panthenol, sclerotium gum, xanthan gum, cetearyl glucoside, behenyl alcohol, dimethicone, ophiopogon japonicus root extract, hydroxyacetophenone, 4-t-butylcyclohexanol, PPG-4-ceteth-20, arachidyl glucoside, ethylhexylglycerin, sodium hyaluronate, ceramide NG, 1,2-hexanediol, maltodextrin, dipropylene glycol, glucose, trisodium ethylenediamine disuccinate.
How to Use: Gently apply to the eyelids as needed. 15ml tube.
Sign in to review this product if you bought it.
No reviews yet.